COVID-19 Pandemic - The government presents its daily update
QUÉBEC CITY, Feb. 21, 2023 /CNW/ - The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:
606 new cases, bringing the total number of people infected to 1,312,991*;
10 new deaths, for a total of 18,073 deaths, i.e.;
1 death in the last 24 hours,
7 deaths that occurred between two and seven days ago,
2 deaths that occurred more than seven days ago; NOTE: As death removals are not shown in the data above, the number of death additions may exceed the number of new deaths for the day.
1,911 health care workers absent for COVID-related reasons (preventive withdrawal, isolation, awaiting results, etc.);
1,291 hospitalizations, including 461 due to COVID-19, for an increase of 2 compared to the previous day;
212 new entries,
210 new discharges;
34 people in intensive care, including 25 due to COVID-19, which remains stable compared to the previous day;
13 new entries,
13 new discharges;
5,829 samples conducted on February 19;
324,583 self-declared rapid tests so far, including 273,895 positive: 43 declared for yesterday, including 37 positive.
*Note that the number of cases listed is not representative of the situation since access to screening centres is restricted to priority clienteles.
Vaccination
1 201 doses administered are added, for a cumulative total of 22,912,274 doses received by Quebecers.
To follow the evolution of the data on a daily basis, consult the open data or the INSPQ website at https://www.donneesquebec.ca/recherche/fr/organization/msss or at https://www.inspq.qc.ca/covid-19/donnees. Note that certain data, especially the number of cases, deaths and doses administered, may be subject to daily readjustment for previous days, given that a catch-up is necessary due to a delay in data entry.
A reminder concerning public health instructions:
To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect.
Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...